Today: 28 February 2026
Subscribe
Browse Category

NYSE:MO 30 October 2025 - 30 January 2026

Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria shares rose 3.1% to $61.61 Friday, rebounding after Thursday’s earnings report sent the stock lower. The company named CFO Salvatore Mancuso as incoming CEO, effective May 14, and is expanding exports to tap a federal excise-tax rebate. Altria’s Q4 net revenue fell 2.1% to $5.846 billion, with adjusted EPS at $1.30. Market share for its on! pouches dropped to 13% as competition from Philip Morris’s Zyn intensified.
30 January 2026
·
Altria Stock (MO) News: Dividend Reset, FDA on! PLUS Authorization, and NJOY Legal Battle—What Investors Need Before Monday

Altria Stock (MO) News: Dividend Reset, FDA on! PLUS Authorization, and NJOY Legal Battle—What Investors Need Before Monday

Altria shares closed at $57.60 Friday, down 2.33% after the stock went ex-dividend for a $1.06 payout payable Jan. 9. After-hours trading showed little change, with MO near $57.64. The drop followed the ex-dividend adjustment and came as Altria notched a regulatory win for on! PLUS nicotine pouches and faced ongoing NJOY-Juul legal disputes.
28 December 2025
··
Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria Group Stock (MO) Slides After Ex-Dividend Session as Investors Track NJOY Legal Fight and FDA Green Light for on! PLUS Nicotine Pouches

Altria shares fell 2.34% to $57.60 Friday as the stock traded ex-dividend, with the $1.06 per share payout set for Jan. 9. Juul Labs asked an Arizona judge to block Altria and NJOY from using documents uploaded to a UCSF database, arguing the records could affect a vape patent dispute. The broader market saw light trading and finished slightly lower.
27 December 2025
··
Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

Altria (MO) Stock in Focus: FDA Clears on! PLUS Nicotine Pouches, Dividend Dates, and the Latest Analyst Forecasts Into 2026

The FDA late Friday authorized marketing of six on! PLUS nicotine pouch products, the first such decision under a new pilot review program. Altria shares closed at $58.07, market cap $97.48 billion, ahead of a key dividend ex-date and after the company confirmed plans to resume retail and online sales for the approved pouches. The authorization covers three flavors in two strengths, with strict packaging and marketing restrictions.
21 December 2025
··
Altria (MO) Stock News Today: Big Institutional Moves, 7%+ Dividend Yield and a Valuation Debate – November 29, 2025

Altria (MO) Stock News Today: Big Institutional Moves, 7%+ Dividend Yield and a Valuation Debate – November 29, 2025

Altria shares closed at $59.01 on November 28, 2025, with a forward dividend yield near 7.2% and a market cap just under $99 billion. Groupama Asset Management increased its stake by 18.9% in Q2, while other institutional filings showed mixed activity. Debate continued over whether Altria is undervalued or a value trap, following a widely circulated analysis.
30 November 2025
·
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria reported Q3 net revenue down 3% to $6.07 billion and adjusted EPS of $1.45, matching estimates. Shares fell nearly 4% pre-market, trading about 10% below recent highs. The company doubled its buyback program to $2 billion and raised its 2025 earnings outlook floor. Cigarette and oral tobacco sales declined, while NJOY e-cigarette sales remain halted due to a patent dispute.
30 October 2025
···
Go toTop